Results 271 to 280 of about 232,551 (308)

Magnesium-assisted hydrogen improves isoproterenol-induced heart failure. [PDF]

open access: yesMed Gas Res
Chen F   +7 more
europepmc   +1 more source

Targeting SHP‐1‐Mediated Inhibition of STAT3 and ERK Signalling Pathways Rescues the Hyporesponsiveness of MHC‐I‐Deficient NK‐92MI

open access: yesCell Proliferation, EarlyView.
B2M knockout (KO) represents a crucial strategy for generating universal NK‐92MI cell products. This approach results in increased phosphorylation of SHP‐1 and inhibited phosphorylation of STAT3 and ERK, which ultimately affect their cytotoxic capabilities. SHP‐1 KO facilitates the restoration of cytotoxic function in B2M KO NK‐92MI cells.
Kuo Yu   +17 more
wiley   +1 more source

Synergistical Induction of Apoptosis via Cold Atmospheric Plasma and Nanohydroxyapatite for Selective Inhibition of Oral Squamous Cell Carcinoma in Tumour Microenvironment

open access: yesCell Proliferation, EarlyView.
The synergistic effects of microwave‐induced CAP and pH‐responsive NH2‐nHA on OSCC cells were investigated, unveiling novel molecular mechanisms. The study highlights CAP+NH2‐nHA's dual action, inducing diverse apoptotic pathways and establishing a ROS‐Ca2+ amplifying loop, promising in cancer therapy.
Wenting Qi   +6 more
wiley   +1 more source

Research Advances of the Autophagy‐Regulated Radiosensitivity

open access: yesCell Proliferation, EarlyView.
Autophagy plays a dual role in regulating cellular radiosensitivity in radiotherapy (RT). We discuss the mechanisms by which autophagy promotes survival and growthsuppression by modulating radiosensitivity. It also outlines some frontier autophagy‐targeted radiotherapies. ABSTRACT Autophagy is an evolutionarily conserved process of cell self‐catabolism
Hanyue Liu   +7 more
wiley   +1 more source

Herbal Medicine for Colorectal Cancer Treatment: Molecular Mechanisms and Clinical Applications

open access: yesCell Proliferation, EarlyView.
Colorectal cancer is a prevalent gastrointestinal tumour and the second deadliest cancer worldwide, affecting approximately 10% of all cancers and cancer‐related deaths. Current clinical methods for treating CRC cause gastrointestinal abnormalities and myelosuppression.
Zuqing Su   +5 more
wiley   +1 more source

Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. [PDF]

open access: yesCancers (Basel)
Kinloch AJ   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy